Universe Historical Cash Flow
| UPC Stock | USD 0.62 0.07 10.14% |
Analysis of Universe Pharmaceuticals cash flow over time is an excellent tool to project Universe Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 4 M or Free Cash Flow of 1 M as it is a great indicator of Universe Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Universe Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Universe Pharmaceuticals is a good buy for the upcoming year.
Universe |
About Universe Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Universe balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Universe's non-liquid assets can be easily converted into cash.
Universe Pharmaceuticals Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Universe Pharmaceuticals value has been used up. For tax purposes Universe Pharmaceuticals can deduct the cost of the tangible assets it purchases as business expenses. However, Universe Pharmaceuticals must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Capital Expenditures
Capital Expenditures are funds used by Universe Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Universe Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Universe Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Universe Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Universe Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Universe Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.At present, Universe Pharmaceuticals' Free Cash Flow is projected to decrease significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 8 M, whereas Change To Inventory is projected to grow to (1 M).
Universe Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Universe Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Universe Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 888.6K | (451.6K) | 16.6K | (1.2M) | (1.1M) | (1.0M) | |
| Investments | (51.8K) | (13.5M) | (3.9M) | (44.2K) | (39.8K) | (41.7K) | |
| Change In Cash | 6.9M | (2.0M) | (2.4M) | (426.2K) | (383.6K) | (402.8K) | |
| Net Borrowings | 1.1K | 911.2K | 624.4K | 3.3M | 3.8M | 4.0M | |
| Free Cash Flow | 6.1M | (15.6M) | (1.4M) | 1.1M | 968.3K | 1.0M | |
| Change In Working Capital | (1.9M) | (12.7M) | 6.6M | 6.6M | 7.6M | 8.0M | |
| Begin Period Cash Flow | 3.2M | 10.1M | 8.1M | 5.7M | 6.6M | 7.4M | |
| Total Cashflows From Investing Activities | (86.0K) | (51.8K) | (27.1M) | (3.9M) | (3.5M) | (3.7M) | |
| Other Cashflows From Financing Activities | (441.1K) | (2.8M) | 3.3M | (44.2K) | (39.8K) | (37.8K) | |
| Depreciation | 410.1K | 446.9K | 533.9K | 508.8K | 585.1K | 508.0K | |
| Other Non Cash Items | 22.7K | (468.2K) | 906.6K | (526.9K) | (474.2K) | (450.5K) | |
| Capital Expenditures | 51.8K | 13.5M | 93.7K | 44.2K | 50.8K | 48.3K | |
| Total Cash From Operating Activities | 6.1M | (2.1M) | (1.3M) | 1.1M | 1.0M | 957.7K | |
| Change To Account Receivables | (4.1M) | (3.9M) | (1.5M) | 4.7M | 5.4M | 5.7M | |
| Change To Operating Activities | 154.1K | (18.0K) | (7.8M) | 8.2M | 9.5M | 10.0M | |
| Net Income | 7.6M | 11.3M | (8.7M) | (6.2M) | (5.5M) | (5.3M) | |
| Total Cash From Financing Activities | 470.1K | 26.6M | 3.3M | (1.4M) | (1.6M) | (1.5M) | |
| End Period Cash Flow | 10.1M | 8.1M | 5.7M | 5.3M | 6.1M | 7.1M | |
| Change To Netincome | 73.2K | 12.8K | (1.1M) | 301.3K | 271.2K | 284.7K | |
| Change To Liabilities | (924.4K) | 639.4K | 2.5M | (1.9M) | (1.7M) | (1.6M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (76.35) | Revenue Per Share 7.351 | Quarterly Revenue Growth (0.30) | Return On Assets (0.06) |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.